Table 5

Multivariate survival analysis

Survival analysisHR for death (95% CI)P
Performance status (2 vs. 0,1)2.45 (1.34–4.48)0.004
Baseline VEGF (>28 vs. ≤28 pg/ml)1.72 (1.09–2.71)0.020
Baseline PSA (>131 vs. ≤131 ng/ml)1.61 (1.02–2.53)0.040